| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.2B | $8.0B | $6.9B | $5.5B | $4.3B | $1.0B | $0.8B | $2.3B |
| Cost of Revenue | $2.5B | $2.1B | $1.9B | $1.7B | $1.3B | $0.3B | $0.2B | $0.2B |
| Gross Profit | $6.8B | $6.0B | $5.0B | $3.8B | $3.0B | $0.7B | $0.6B | $0.5B |
| R&D Expense | $2.0B | $1.8B | $1.6B | $1.4B | $1.1B | $0.2B | $0.2B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.2B | $0.7B | $0.4B | $-0.2B | $-0.3B | $-0.0B | $-0.0B | $0.0B |
| Net Income | $1.1B | $2.6B | $0.4B | $-0.3B | $-0.5B | $-0.1B | $-0.0B | $-0.0B |
| EPS (Basic) | $1.71 | $8.07 | $1.45 | $-2.71 | $-5.18 | — | $0.08 | — |
| EPS (Diluted) | $1.60 | $7.28 | $1.28 | $-2.71 | $-5.18 | — | $0.07 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.6B | $20.0B | $14.5B | $12.3B | $10.2B | $9.1B | $6.6B | $5.8B |
| Current Assets | $7.5B | $6.8B | $6.0B | $6.4B | $4.6B | $5.1B | $3.7B | $4.1B |
| Cash & Equivalents | $2.3B | $1.5B | $1.1B | $2.1B | $1.9B | $3.0B | $1.0B | $2.5B |
| Total Liabilities | $15.8B | $14.8B | $12.8B | $12.0B | — | — | — | — |
| Current Liabilities | $8.0B | $7.7B | $7.7B | $8.3B | $5.1B | $2.7B | $2.1B | $2.1B |
| Stockholders' Equity | $7.8B | $5.2B | $1.7B | $0.2B | $0.6B | $1.1B | $1.6B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $3.3B | $2.8B | $2.0B | $1.5B | $1.0B | $1.1B | $1.0B |
| Investing Cash Flow | $-2.2B | $-1.5B | $-2.0B | $-0.9B | $-1.5B | $0.3B | $-1.8B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-1.3B | $-1.7B | $-0.8B | $-1.1B | $0.7B | $-0.8B | $1.2B |